Find Clinical Trial

Home » Find Clinical Trials » Assessment of the effects on 24-hour ambulatory blood pressure and the safety of a once-a-day oral 8 mg perindopril morning administration versus evening administration in hypertensive patients. An 8-week, 2-arm, randomised, double-blind study.

Assessment of the effects on 24-hour ambulatory blood pressure and the safety of a once-a-day oral 8 mg perindopril morning administration versus evening administration in hypertensive patients. An 8-week, 2-arm, randomised, double-blind study.

← Back

Study Phase	Phase 2

Therapeutic Area	Cardiovascular Diseases

Indication	Hypertension

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	PERINDOPRIL TERT BUTYLAMINE, S009490

Active Substance Code	S009490

Protocol Code	CL2-09490-157

EudraCT Code	2007-007026-22

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.